Precigen (PGEN) Stock Chart & Stock Price History → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free PGEN Stock Alerts $1.32 -0.02 (-1.13%) (As of 10:50 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Precigen Stock Price Performance5 Day Performance-6.34%1 Month Performance-5.67%3 Month Performance-3.97%6 Month Performance+5.56%Year-To-Date Performance-0.75%1 Year Performance+6.40% Receive PGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precigen and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here PGEN Stock Chart for Thursday, May, 9, 2024 PGEN Chart by TradingView Precigen Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$1.38$1.33-3.62%$1.38$1.30781,987 shs$331.06 million05/07/2024$1.44$1.38-4.17%$1.42$1.36905,652 shs$343.51 million05/06/2024$1.42$1.44+1.41%$1.45$1.40595,600 shs$358.45 million05/03/2024$1.40$1.42+1.43%$1.49$1.39599,718 shs$353.47 million05/02/2024$1.40$1.40$1.44$1.33753,686 shs$348.49 million05/01/2024$1.32$1.40+6.06%$1.46$1.31683,622 shs$348.49 million Get the Latest News and Ratings for PGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Precigen and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$1.40$1.32-5.71%$1.41$1.32496,536 shs$328.57 million04/29/2024$1.41$1.40-0.71%$1.46$1.40381,223 shs$348.49 million04/26/2024$1.40$1.41+0.71%$1.44$1.39413,569 shs$350.98 million04/25/2024$1.42$1.40-1.41%$1.41$1.37610,769 shs$348.49 million04/24/2024$1.40$1.42+1.43%$1.43$1.39558,930 shs$353.47 million04/23/2024$1.38$1.40+1.45%$1.45$1.39507,017 shs$348.49 million04/22/2024$1.33$1.38+3.76%$1.39$1.32888,547 shs$343.51 million04/19/2024$1.32$1.33+0.76%$1.34$1.281.01 million shs$331.06 million04/18/2024$1.31$1.32+0.76%$1.36$1.281.12 million shs$328.57 million04/17/2024$1.36$1.31-3.68%$1.41$1.30811,066 shs$326.09 million04/16/2024$1.40$1.36-2.86%$1.42$1.33847,785 shs$338.53 million04/15/2024$1.42$1.40-1.41%$1.42$1.381.22 million shs$348.49 million04/12/2024$1.45$1.42-2.07%$1.44$1.38932,023 shs$353.47 million04/11/2024$1.41$1.45+2.84%$1.48$1.42695,083 shs$360.93 million04/10/2024$1.41$1.41$1.41$1.331.25 million shs$350.98 million04/09/2024$1.41$1.41$1.46$1.40312,802 shs$350.98 million04/08/2024$1.40$1.41+0.71%$1.46$1.40649,138 shs$350.98 million04/05/2024$1.36$1.40+2.94%$1.43$1.35515,237 shs$348.49 million04/04/2024$1.40$1.36-2.86%$1.42$1.36618,109 shs$338.53 million04/03/2024$1.39$1.40+0.72%$1.41$1.35634,714 shs$348.49 million04/02/2024$1.43$1.39-2.80%$1.41$1.36823,236 shs$346.00 million04/01/2024$1.45$1.43-1.38%$1.49$1.42520,462 shs$355.96 million03/29/2024$1.45$1.45$1.47$1.42691,924 shs$360.93 million03/28/2024$1.45$1.45$1.47$1.42676,398 shs$360.93 million03/27/2024$1.40$1.45+3.57%$1.45$1.39467,156 shs$360.93 million03/26/2024$1.41$1.40-0.36%$1.43$1.391.13 million shs$348.49 million03/25/2024$1.40$1.41+0.72%$1.41$1.39558,521 shs$349.73 million03/22/2024$1.53$1.40-8.82%$1.46$1.371.48 million shs$347.24 million03/21/2024$1.44$1.53+6.25%$1.60$1.461.54 million shs$380.85 million03/20/2024$1.44$1.44$1.47$1.351.97 million shs$358.44 million03/19/2024$1.39$1.44+3.60%$1.48$1.391.12 million shs$358.45 million03/18/2024$1.43$1.39-2.80%$1.46$1.39796,963 shs$346.00 million03/15/2024$1.43$1.43$1.53$1.411.58 million shs$355.95 million03/14/2024$1.52$1.43-5.92%$1.55$1.411.02 million shs$355.96 millionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/13/2024$1.51$1.52+1.00%$1.57$1.48695,579 shs$378.36 million03/12/2024$1.56$1.51-3.22%$1.58$1.49708,677 shs$374.63 million03/11/2024$1.75$1.56-11.14%$1.79$1.561.28 million shs$387.07 million03/08/2024$1.67$1.75+4.79%$1.78$1.691.27 million shs$435.61 million03/07/2024$1.68$1.67-0.60%$1.74$1.65997,482 shs$415.70 million03/06/2024$1.61$1.68+4.35%$1.70$1.61899,709 shs$418.19 million03/05/2024$1.63$1.61-1.23%$1.67$1.58808,684 shs$400.76 million03/04/2024$1.69$1.63-3.55%$1.71$1.601.09 million shs$405.74 million03/01/2024$1.54$1.69+9.74%$1.70$1.541.28 million shs$420.67 million02/29/2024$1.52$1.54+1.32%$1.61$1.541.29 million shs$383.34 million02/28/2024$1.62$1.52-6.17%$1.63$1.461.67 million shs$378.36 million02/27/2024$1.53$1.62+5.88%$1.70$1.502.01 million shs$403.25 million02/26/2024$1.46$1.53+4.79%$1.66$1.462.24 million shs$380.85 million02/23/2024$1.44$1.46+1.39%$1.48$1.411.04 million shs$363.42 million02/22/2024$1.42$1.44+1.41%$1.47$1.421.14 million shs$358.45 million02/21/2024$1.42$1.42$1.46$1.41627,305 shs$353.47 million02/20/2024$1.42$1.42$1.50$1.401.10 million shs$353.47 million02/19/2024$1.42$1.42$1.45$1.41926,800 shs$353.47 million02/16/2024$1.43$1.42-0.70%$1.45$1.41924,682 shs$353.47 million02/15/2024$1.40$1.43+2.14%$1.44$1.37996,546 shs$355.96 million02/14/2024$1.31$1.40+6.87%$1.41$1.331.32 million shs$348.49 million02/13/2024$1.43$1.31-8.39%$1.41$1.302.34 million shs$326.09 million02/12/2024$1.40$1.43+2.14%$1.45$1.37955,190 shs$355.96 million02/09/2024$1.39$1.40+1.08%$1.42$1.37650,190 shs$348.49 million02/08/2024$1.38$1.39+0.36%$1.41$1.36530,654 shs$344.75 million02/07/2024$1.43$1.38-3.50%$1.42$1.37855,989 shs$343.51 million Related Companies: NKTX Stock Chart TERN Stock Chart ATAI Stock Chart URGN Stock Chart RANI Stock Chart NLTX Stock Chart SBTX Stock Chart AVIR Stock Chart ORGO Stock Chart HRTX Stock Chart Receive PGEN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Precigen and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PGEN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.